Empiric treatment of serious infections in patients with cancer: Randomised comparison of two combinations
- 1 June 1991
- journal article
- clinical trial
- Published by Springer Nature in Infection
- Vol. 19 (6) , S326-S329
- https://doi.org/10.1007/bf01715773
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Third Generation Cephalosporins: Safety Profiles After 10 Years of Clinical UseThe Journal of Clinical Pharmacology, 1990
- Comparative study of three different dosing regimens of cefotaxime for treatment of gram-negative bacteremiaDiagnostic Microbiology and Infectious Disease, 1989
- Evaluation of cefotaxime alone and in combination with desacetylacefotaxime against strains of Staphylococcus aureus that produce variants of staphylococcal β-lactamaseDiagnostic Microbiology and Infectious Disease, 1989
- Comparison of the in vitro action and interaction of cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides spp.Diagnostic Microbiology and Infectious Disease, 1989
- Effectiveness of cefotaxime alone and in combination with desacetylcefotaxime against Bacteroides fragilisDiagnostic Microbiology and Infectious Disease, 1989
- A review of cephalosporin metabolism: A lesson to be learned for future chemotherapyDiagnostic Microbiology and Infectious Disease, 1989
- Therapy of small cell lung cancer: Anything new?European Journal of Cancer and Clinical Oncology, 1988
- Ceftazidime Combined with a Short or Long Course of Amikacin for Empirical Therapy of Gram-Negative Bacteremia in Cancer Patients with GranulocytopeniaNew England Journal of Medicine, 1987
- Empirical Antimicrobial Therapy in the Neutropenic HostNew England Journal of Medicine, 1986
- Cefotaxime versus Ampicillin, Methicillin and Netilmicin in Combination for Treatment of Febrile Episodes in Patients with Haematologic MalignancyActa Medica Scandinavica, 1983